Latest
Novartis biosimilar works as well as Amgen’s Neulasta
Swiss pharmaceutical Novartis announced Monday that a copycat version of Amgen’s Neulasta works just as well to prevent a condition that can lead to infection in women with breast cancer. Neulasta stimulates white blood cell production in the body, which helps the body fight cancer. Novartis’ new drug is part of a new class of Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
